ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population
- PMID: 16176061
- DOI: 10.1007/s11064-005-2745-6
ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population
Abstract
Apolipoprotein E gene (Apo(epsilon)) has three common alleles (epsilon2, epsilon3, and epsilon4), of which epsilon4 has been shown to be associated with an increased risk for Alzheimer's disease (AD). Possible additional genetic factors, like the -491A variant of ApoE promoter may modify the development of AD, independently of the ApoE allele status. The objective of this study was to investigate whether A/T allelic polymorphism at site-491 of the ApoE promoter is associated with AD in a Hungarian population. The genomic DNA isolated from peripheral blood lymphocytes of 52 late-onset AD and 53 control individuals was used as a template for the two examined polymorphisms and PCR assay was applied. The epsilon4 allele was significantly over-represented in the AD group (28%) as compared with the control population (7%). No significant differences have been found between the control and the AD populations regarding the occurrence of the promoter A allele frequencies (control: 77%, AD: 70%). However, the AA genotype was more frequent in the AD group (48%) than in the control (10%) when the presence of epsilon4 allele was also considered. It is unlikely therefore that the -491A variant of the ApoE promoter gene is an independent risk factor in the Hungarian AD population, but a linkage disequilibrium exists between the two examined mutations.
Similar articles
-
Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.J Neurol. 1999 Sep;246(9):821-4. doi: 10.1007/s004150050461. J Neurol. 1999. PMID: 10525981 Clinical Trial.
-
The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism.Neurosci Lett. 1998 Aug 14;252(2):95-8. doi: 10.1016/s0304-3940(98)00567-9. Neurosci Lett. 1998. PMID: 9756330
-
Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.Hum Mol Genet. 1998 Sep;7(9):1511-6. doi: 10.1093/hmg/7.9.1511. Hum Mol Genet. 1998. PMID: 9700208
-
Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.J Neurochem. 2003 Mar;84(6):1215-36. doi: 10.1046/j.1471-4159.2003.01615.x. J Neurochem. 2003. PMID: 12614323 Review.
-
Genetic analysis of vascular factors in Alzheimer's disease.Ann N Y Acad Sci. 2002 Nov;977:232-8. doi: 10.1111/j.1749-6632.2002.tb04820.x. Ann N Y Acad Sci. 2002. PMID: 12480755 Review.
Cited by
-
Association between ε2/3/4, promoter polymorphism (-491A/T, -427T/C, and -219T/G) at the apolipoprotein E gene, and mental retardation in children from an iodine deficiency area, China.Biomed Res Int. 2014;2014:236702. doi: 10.1155/2014/236702. Epub 2014 Mar 25. Biomed Res Int. 2014. PMID: 24790992 Free PMC article.
-
Association between polymorphisms in the promoter region of the apolipoprotein E (APOE) gene and Alzheimer's disease: A meta-analysis.EXCLI J. 2017 Jun 20;16:921-938. doi: 10.17179/excli2017-289. eCollection 2017. EXCLI J. 2017. PMID: 28900374 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous